Onex saw the highest growth of 0.99% in patent filings in June and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Onex‘s patent filings and grants. Buy the databook here.
Onex has been focused on protecting inventions in United States(US) with 11 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 88% filings and 80% grants. The United States(US), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Onex is filings its patents. Among the top granted patent authorities, Onex has 80% of its grants in United States(US) and 20% in European Patent Office(EPO).
Fujifilm and Siemens could be the strongest competitors for Onex
In terms of grant share, Onex stands in seventh position among its competitors. Fujifilm and Siemens secured the top positions according to recent patent publication data.
Patents related to industrial automation and healthtech lead Onex's portfolio
Onex has the highest number of patents in industrial automation followed by, healthtech and smart hospitals. For industrial automation, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Diagnostic imaging related patents lead Onex portfolio followed by lithium ion (li-ion) batteries, and electric and electronic distribution
Onex has highest number of patents in diagnostic imaging followed by lithium ion (li-ion) batteries, electric and electronic distribution, healthcare it, and critical care.
For comprehensive analysis of Onex's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.